NO20054728L - Preparat for administrering av jern for behandling av rastlose ben syndrom - Google Patents

Preparat for administrering av jern for behandling av rastlose ben syndrom

Info

Publication number
NO20054728L
NO20054728L NO20054728A NO20054728A NO20054728L NO 20054728 L NO20054728 L NO 20054728L NO 20054728 A NO20054728 A NO 20054728A NO 20054728 A NO20054728 A NO 20054728A NO 20054728 L NO20054728 L NO 20054728L
Authority
NO
Norway
Prior art keywords
iron
administration
preparation
treatment
restless leg
Prior art date
Application number
NO20054728A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054728D0 (no
Inventor
Mary Jane Helenek
Ralf A Lange
Fred B Oldham
Marc L Tokars
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of NO20054728D0 publication Critical patent/NO20054728D0/no
Publication of NO20054728L publication Critical patent/NO20054728L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20054728A 2003-03-14 2005-10-13 Preparat for administrering av jern for behandling av rastlose ben syndrom NO20054728L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/389,228 US6960571B2 (en) 2003-03-14 2003-03-14 Methods and compositions for administration of iron for the treatment of restless leg syndrome
PCT/US2003/015087 WO2004082693A1 (en) 2003-03-14 2003-05-13 Composition for administration of iron for the treatment of restless legs syndrome

Publications (2)

Publication Number Publication Date
NO20054728D0 NO20054728D0 (no) 2005-10-13
NO20054728L true NO20054728L (no) 2005-12-13

Family

ID=32962229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054728A NO20054728L (no) 2003-03-14 2005-10-13 Preparat for administrering av jern for behandling av rastlose ben syndrom

Country Status (25)

Country Link
US (1) US6960571B2 (pl)
EP (1) EP1603580B1 (pl)
JP (2) JP2006520322A (pl)
KR (1) KR100978377B1 (pl)
CN (1) CN1771044B (pl)
AT (1) ATE400280T1 (pl)
AU (1) AU2003249635C1 (pl)
BR (1) BR0318185A (pl)
CA (1) CA2518971C (pl)
CY (1) CY1110407T1 (pl)
DE (1) DE60322121D1 (pl)
DK (1) DK1603580T3 (pl)
ES (1) ES2309403T3 (pl)
HR (1) HRP20050796A2 (pl)
IL (1) IL170386A (pl)
MX (1) MXPA05009786A (pl)
NO (1) NO20054728L (pl)
PL (1) PL206810B1 (pl)
PT (1) PT1603580E (pl)
RS (1) RS51823B (pl)
RU (1) RU2319490C2 (pl)
SI (1) SI1603580T1 (pl)
UA (1) UA83483C2 (pl)
WO (1) WO2004082693A1 (pl)
ZA (1) ZA200508308B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1655040A1 (en) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Contrast agent formulations for the visualization of the lymphatic system
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
KR20080078075A (ko) * 2005-12-20 2008-08-26 세레우사이언스 아베 하지 불안 증후군의 치료 및 진단을 위한 방법 및 조성물
CN102861336A (zh) * 2005-12-23 2013-01-09 阿贾伊·古普塔 含铁的肠胃外营养组合物
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
EP3081219A1 (en) 2006-01-06 2016-10-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
EP1941869A1 (en) * 2007-01-04 2008-07-09 Vifor (International) Ag Multicompartment bag for storage of iron preparations
CA2719577C (en) * 2008-03-28 2016-11-22 Chyna Llc Use of ferritin to treat iron deficiency disorders
EP2296998A1 (en) * 2008-05-23 2011-03-23 Hospira, Inc. Packaged iron sucrose products
US20100160295A1 (en) * 2008-11-06 2010-06-24 Synosia Therapeutics Treatment of restless leg syndrome and sleep disorders
MX2011009936A (es) 2009-03-25 2011-10-06 Pharmacosmos Holding As Un compuesto de oligosacarido de hierro estable.
US8058076B2 (en) * 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN102440999A (zh) * 2010-10-15 2012-05-09 天津瑞普生物技术股份有限公司 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
EP2968503B1 (en) 2013-03-15 2018-08-15 Intrinsic LifeSciences LLC Anti-hepcidin antibodies and uses thereof
JP2014132029A (ja) * 2014-04-03 2014-07-17 Chyna Llc 鉄欠乏性障害を治療するためのフェリチンの使用
WO2016049036A1 (en) 2014-09-22 2016-03-31 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
WO2016069950A2 (en) * 2014-10-29 2016-05-06 University Of Utah Research Foundation Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1)
EP2913054A1 (en) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)
WO2023028252A1 (en) 2021-08-27 2023-03-02 American Regent, Inc. Iron compositions and methods of making and using them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248492A (en) * 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5700832A (en) * 1994-10-19 1997-12-23 Daewon Pharm. Co., Ltd. Antianemic agent containing iron and difructose
RU2153351C2 (ru) * 1995-12-14 2000-07-27 Закрытое акционерное общество "ВАМ" Средство для регулирования эндогенной продукции цитокинов и гемопоэтических факторов (варианты) и способ его использования
SE9803760D0 (sv) 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
AU2001251306A1 (en) 2000-04-04 2001-10-15 Siegel, Jerome M. Treatment of sleep disorders with hypocretin-1

Also Published As

Publication number Publication date
JP2006520322A (ja) 2006-09-07
CA2518971C (en) 2009-02-17
ATE400280T1 (de) 2008-07-15
CN1771044A (zh) 2006-05-10
BR0318185A (pt) 2006-03-21
AU2003249635C1 (en) 2009-11-05
RS20050695A (sr) 2008-04-04
DE60322121D1 (de) 2008-08-21
IL170386A (en) 2013-03-24
ES2309403T3 (es) 2008-12-16
WO2004082693A1 (en) 2004-09-30
PT1603580E (pt) 2008-09-10
SI1603580T1 (sl) 2009-04-30
CY1110407T1 (el) 2015-04-29
EP1603580B1 (en) 2008-07-09
AU2003249635B2 (en) 2009-06-04
PL378875A1 (pl) 2006-05-29
US20040180849A1 (en) 2004-09-16
UA83483C2 (uk) 2008-07-25
ZA200508308B (en) 2006-10-25
HK1089666A1 (en) 2006-12-08
PL206810B1 (pl) 2010-09-30
NO20054728D0 (no) 2005-10-13
RU2005131832A (ru) 2006-03-20
HRP20050796A2 (en) 2005-12-31
CA2518971A1 (en) 2004-09-30
RU2319490C2 (ru) 2008-03-20
KR20060082032A (ko) 2006-07-14
US6960571B2 (en) 2005-11-01
EP1603580A1 (en) 2005-12-14
AU2003249635A1 (en) 2004-10-11
MXPA05009786A (es) 2006-03-08
JP2010180252A (ja) 2010-08-19
CN1771044B (zh) 2012-09-19
DK1603580T3 (da) 2008-10-06
RS51823B (sr) 2012-02-29
KR100978377B1 (ko) 2010-08-30

Similar Documents

Publication Publication Date Title
NO20054728D0 (no) Preparat for administrering av jern for behandling av rastlose ben syndrom
BRPI0507984A (pt) composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamìfero, para melhorar a resistência de insulina em um mamìfero e para prevenir ou tratar doenças circulatórias em um mamìfero, e, uso do composto
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
CY1111478T1 (el) Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
MY132789A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
PL410218A1 (pl) Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie
NO20070113L (no) Opioider for behandling av restless legs syndromet
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
IL164195A0 (en) Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform
MXPA05013901A (es) Uso de acido alfa-cetoglutarico para tratamiento de desnutricion o condicion de glucosa alta en plasma.
ATE395936T1 (de) Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten
SE0102887D0 (sv) New formulation
TW200514582A (en) Transdermal preparation and method for reducing side effect in pergolide therapy
PL372313A1 (pl) Sposób wytwarzania pseudo-wysepek
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
EA200400817A1 (ru) Идрапаринукс для лечения и вторичной профилактики случаев венозной тромбоэмболии у пациентов с тромбозом глубоких вен
DE60216090D1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application